SMS Lifesciences India Limited (BOM:540679)

Market Cap	3.96B
Revenue (ttm)	3.46B
Net Income (ttm)	230.40M
Shares Out	n/a
EPS (ttm)	76.19
PE Ratio	17.19
Forward PE	n/a
Dividend	1.50 (0.10%)
Ex-Dividend Date	Sep 23, 2024

Volume	868
Average Volume	721
Open	1,349.45
Previous Close	1,333.75
Day's Range	1,305.55 - 1,371.55
52-Week Range	630.75 - 1,747.85
Beta	n/a
RSI	51.90
Earnings Date	May 27, 2025

About SMS Lifesciences India

SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as anti ulcer, erectile dysfunction, anti gout, anesthesia, anti infective, anti obesity, antifungal, anti convulsant, anti emetic, ophthalmic, anti worm, and antiemetic. It is also developing APIs in the areas of anti depressant, anti psychotic, anti hypertension, veterinary, antiviral, and anticoagulant. In addition, the company offers intermediates in the anti ul...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 574
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540679

Financial Performance

In 2023, SMS Lifesciences India's revenue was 3.06 billion, a decrease of -3.04% compared to the previous year's 3.16 billion. Earnings were 90.93 million, a decrease of -20.68%.